Bacterial DNA gyrase and topoisomerase IV are selective targets of fluoroquinolones. Topoisomerase IV versus gyrase and Gram-positive versus Gram-negative behavior was studied based on the different recognition of DNA sequences by topoisomerase– quinolone complexes. A careful statistical analysis of preferred bases was performed on a large number (>400) of cleavage sites. We found discrete preferred sequences that were similar when using different enzymes (i.e. gyrase and topoisomerase IV) from the same bacterial source, but in part diverse when employing enzymes from different origins (i.e. Escherichia coli and Streptococcus pneumoniae). Subsequent analysis on the wild-type and mutated consensus sequences showed that: (i) Gn/Cn-rich seq...
Herein, we describe the discovery and optimization of a novel series that inhibits bacterial DNA gyr...
Type II topoisomerases regulate DNA topology by making a double-stranded break in one DNA duplex, tr...
Herein, we describe the discovery and optimization of a novel series that inhibits bacterial DNA gyr...
Bacterial DNA gyrase and topoisomerase IV are selective targets of fluoroquinolones. Topoisomerase I...
Abstract Topoisomerase (topo) IV and gyrase are bacterial type IIA DNA topoisomerases essential for ...
Topoisomerase (topo) IV and gyrase are bacterial type IIA DNA topoisomerases essential for DNA repli...
The widely used quinolone antibiotics act by trapping prokaryotic type IIA topoisomerases, resulting...
New antibacterials are needed to tackle antibiotic-resistant bacteria. Type IIA topoisomerases (topo...
Quinolones are a clinically-useful class of antibacterial agents known to target DNA gyrase, a bacte...
As part of a programme of synthesizing and investigating the biological properties of new fluoroquin...
Clerocidin (CL), a diterpenoid natural product, alkylates DNA through its epoxide moiety and exhibit...
Klebsiella pneumoniae is a Gram-negative bacterium that is responsible for a range of common infecti...
A paucity of novel acting antibacterials is in development to treat the rising threat of antimicrobi...
DNA gyrase is a type II topoisomerase that catalyzes the introduction of negative supercoils in the ...
DNA topoisomerases are the targets of important anticancer and antibacterial drugs. Camptothecins an...
Herein, we describe the discovery and optimization of a novel series that inhibits bacterial DNA gyr...
Type II topoisomerases regulate DNA topology by making a double-stranded break in one DNA duplex, tr...
Herein, we describe the discovery and optimization of a novel series that inhibits bacterial DNA gyr...
Bacterial DNA gyrase and topoisomerase IV are selective targets of fluoroquinolones. Topoisomerase I...
Abstract Topoisomerase (topo) IV and gyrase are bacterial type IIA DNA topoisomerases essential for ...
Topoisomerase (topo) IV and gyrase are bacterial type IIA DNA topoisomerases essential for DNA repli...
The widely used quinolone antibiotics act by trapping prokaryotic type IIA topoisomerases, resulting...
New antibacterials are needed to tackle antibiotic-resistant bacteria. Type IIA topoisomerases (topo...
Quinolones are a clinically-useful class of antibacterial agents known to target DNA gyrase, a bacte...
As part of a programme of synthesizing and investigating the biological properties of new fluoroquin...
Clerocidin (CL), a diterpenoid natural product, alkylates DNA through its epoxide moiety and exhibit...
Klebsiella pneumoniae is a Gram-negative bacterium that is responsible for a range of common infecti...
A paucity of novel acting antibacterials is in development to treat the rising threat of antimicrobi...
DNA gyrase is a type II topoisomerase that catalyzes the introduction of negative supercoils in the ...
DNA topoisomerases are the targets of important anticancer and antibacterial drugs. Camptothecins an...
Herein, we describe the discovery and optimization of a novel series that inhibits bacterial DNA gyr...
Type II topoisomerases regulate DNA topology by making a double-stranded break in one DNA duplex, tr...
Herein, we describe the discovery and optimization of a novel series that inhibits bacterial DNA gyr...